Patents by Inventor Jose G. Rocca

Jose G. Rocca has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210023126
    Abstract: A composition and method of providing nitric oxide and nitrite therapy to patients whereby a therapeutic amount is bioavailable within approximately 30 minutes of administration. In embodiments of the invention, nitric oxide is produced in the oral cavity.
    Type: Application
    Filed: October 14, 2020
    Publication date: January 28, 2021
    Inventors: Nathan S. Bryan, Jose G. Rocca
  • Publication number: 20190314404
    Abstract: A composition and method of providing nitric oxide and nitrite therapy to patients whereby a therapeutic amount is bioavailable within approximately 30 minutes of administration. In embodiments of the invention, nitric oxide is produced in the oral cavity.
    Type: Application
    Filed: May 29, 2019
    Publication date: October 17, 2019
    Inventors: Nathan S. Bryan, Jose G. Rocca
  • Patent number: 10342822
    Abstract: A composition and method of providing nitric oxide and nitrite therapy to patients whereby a therapeutic amount is bioavailable within approximately 30 minutes of administration. In embodiments of the invention, nitric oxide is produced in the oral cavity.
    Type: Grant
    Filed: October 19, 2017
    Date of Patent: July 9, 2019
    Assignees: Board of Regents of the University of Texas System, Neogenis Labs, Inc.
    Inventors: Nathan S. Bryan, Jose G. Rocca
  • Publication number: 20180153929
    Abstract: A composition and method of providing nitric oxide and nitrite therapy to patients whereby a therapeutic amount is bioavailable within approximately 30 minutes of administration. In embodiments of the invention, nitric oxide is produced in the oral cavity.
    Type: Application
    Filed: October 19, 2017
    Publication date: June 7, 2018
    Inventors: Nathan S. Bryan, Jose G. Rocca
  • Patent number: 9821006
    Abstract: A composition and method of providing nitric oxide and nitrite therapy to patients whereby a therapeutic amount is bioavailable within approximately 30 minutes of administration. In embodiments of the invention, nitric oxide is produced in the oral cavity.
    Type: Grant
    Filed: January 6, 2016
    Date of Patent: November 21, 2017
    Assignees: Board of Regents of the University of Texas System, Neogenis Labs, Inc.
    Inventors: Nathan S. Bryan, Jose G. Rocca
  • Publication number: 20160287628
    Abstract: A composition and method of providing nitric oxide and nitrite therapy to patients whereby a therapeutic amount is bioavailable within approximately 30 minutes of administration. In embodiments of the invention, nitric oxide is produced in the oral cavity.
    Type: Application
    Filed: January 6, 2016
    Publication date: October 6, 2016
    Inventors: Nathan S. Bryan, Jose G. Rocca
  • Patent number: 9241999
    Abstract: A composition and method of providing nitric oxide and nitrite therapy to patients whereby a therapeutic amount is bioavailable within approximately 30 minutes of administration. In embodiments of the invention, nitric oxide is produced in the oral cavity.
    Type: Grant
    Filed: August 17, 2012
    Date of Patent: January 26, 2016
    Assignees: Board of Regents of the University of Texas System, Neogenis Labs, Inc.
    Inventors: Nathan S. Bryan, Jose G. Rocca
  • Publication number: 20130071371
    Abstract: A composition and method of providing nitric oxide and nitrite therapy to patients whereby a therapeutic amount is bioavailable within approximately 30 minutes of administration. In embodiments of the invention, nitric oxide is produced in the oral cavity.
    Type: Application
    Filed: August 17, 2012
    Publication date: March 21, 2013
    Applicants: NEOGENIS LABS, INC., BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Nathan S. Bryan, Jose G. Rocca
  • Publication number: 20130011482
    Abstract: A medicament delivery system is disclosed. The system comprises a descending formulation for delivering the medicament and an ascending formulation to protect a patient being treated with the medicament from the side effects thereof.
    Type: Application
    Filed: September 14, 2012
    Publication date: January 10, 2013
    Inventors: Jose G. Rocca, Khalid Shah
  • Patent number: 7988992
    Abstract: The present invention features modified superporous hydrogels (SPHs) and methods for their formation. The SPHs of the present invention are prepared by careful selection of the hydrophobic/hydrophilic reactive ingredients and by harmonizing the foaming and polymerization reactions, which results in the formation of SPHs having a homogeneous structure and favorable physical and mechanical properties, including swelling, strength, ruggedness, and resiliency. The SPHs of the present invention are particularly useful when employed in very harsh swelling environments, such as the low pH environment of the gastric fluid of the stomach, for extended periods of time.
    Type: Grant
    Filed: July 6, 2007
    Date of Patent: August 2, 2011
    Assignee: KOS Life Sciences Abbott Laboratories
    Inventors: Hossein Omidian, Jose G. Rocca
  • Publication number: 20090069275
    Abstract: The invention relates to an extended-release matrix formulation capable of being directly compressed into tablets comprising niacin, a release-retarding agent, and other excipients. The resulting tablets of the invention demonstrate favorable release characteristics and a reduction in the severity, duration and incidences of cutaneous flushing commonly associated with niacin treatment.
    Type: Application
    Filed: August 19, 2008
    Publication date: March 12, 2009
    Inventors: Jose G. Rocca, Eugenio Cefali, Yucun Zhu
  • Publication number: 20080206339
    Abstract: The invention relates to methods for preparing superporous hydrogels (SPH) that are very-pure and have desirable swelling properties necessary for commercial use, such as in food and pharmaceutical applications. Such methods include simultaneous use of low and high glass transition monomers to improve impurity and swelling profiles of the SPH, use of an integration means to prepare a very homogenous superporous hydrogel foam, washing the superporous hydrogel in a washing solution comprising different ratios of solvent to non-solvent (e.g., water/alcohol), use of a chemically-induced expansion/contraction process to enhance the efficiency of the multiple washing process and to fully structuralize the SPH, and employing one or more separation techniques, such as rubbing, filtration, centrifugation, compression and cutting to increase the efficiency of the purification process and to enhance the SPH swelling properties.
    Type: Application
    Filed: February 25, 2008
    Publication date: August 28, 2008
    Applicant: Abbott Laboratories
    Inventors: Hossein Omidian, Cristian Gavrilas, Wenli Han, Ge Li, Jose G. Rocca